CCN1 interlinks integrin and Hippo pathway to autoregulate tip cell activity

  1. Myo-Hyeon Park
  2. Ae Kyung Kim
  3. Sarala Manandhar
  4. Su-Young Oh
  5. Gun-Hyuk Jang
  6. Li Kang
  7. Dong-Won Lee
  8. Do Young Hyeon
  9. Sun-Hee Lee
  10. Hye Eun Lee
  11. Tae-Lin Huh
  12. Sang Heon Suh
  13. Daehee Hwang
  14. Kyunghee Byun
  15. Hae-Chul Park
  16. You Mie Lee  Is a corresponding author
  1. Kyungpook National University, Republic of Korea
  2. Korea University, Ansan Hospital, Republic of Korea
  3. POSTECH, Republic of Korea
  4. Chonnam National University Hospital, Republic of Korea
  5. Daegu Gyeongbuk Institute of Science and Technology, Republic of Korea
  6. Gachon University, Republic of Korea

Abstract

CCN1 (CYR61) stimulates active angiogenesis in various tumours, although the mechanism is largely unknown. Here, we report that CCN1 is a key regulator of endothelial tip cell activity in angiogenesis. Microvessel networks and directional vascular cell migration patterns were deformed in ccn1-knockdown zebrafish embryos. CCN1 activated VEGFR2 and downstream MAPK/PI3K signalling pathways, YAP/TAZ, as well as Rho effector mDia1 to enhance tip cell activity and CCN1 itself. VEGFR2 interacted with integrin αvβ3 through CCN1. Integrin αvβ3 inhibitor repressed tip cell number and sprouting in postnatal retinas from endothelial cell-specific Ccn1 transgenic mice, and allograft tumours in Ccn1 transgenic mice showed hyperactive vascular sprouting. Cancer patients with high CCN1 expression have poor survival outcomes and positive correlation with ITGAV and ITGB3 and high YAP/WWTR1. Thus, our data underscore the positive feedback regulation of tip cells by CCN1 through integrin αvβ3/VEGFR2 and increased YAP/TAZ activity, suggesting a promising therapeutic intervention for pathological angiogenesis.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files

Article and author information

Author details

  1. Myo-Hyeon Park

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  2. Ae Kyung Kim

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  3. Sarala Manandhar

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  4. Su-Young Oh

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  5. Gun-Hyuk Jang

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  6. Li Kang

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  7. Dong-Won Lee

    Department of Biomedical Sciences, Korea University, Ansan Hospital, Gyeonggi-do, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  8. Do Young Hyeon

    School of Interdisciplinary Bioscience and Bioengineering, POSTECH, Pohang, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  9. Sun-Hee Lee

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  10. Hye Eun Lee

    College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  11. Tae-Lin Huh

    School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  12. Sang Heon Suh

    Department of Internal Medicine, Chonnam National University Hospital, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  13. Daehee Hwang

    Department of New Biology, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  14. Kyunghee Byun

    School of Medicine, Gachon University, Incheon, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  15. Hae-Chul Park

    Department of Biomedical Sciences, Korea University, Ansan Hospital, Gyeonggi-do, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  16. You Mie Lee

    Collage of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
    For correspondence
    lym@knu.ac.kr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5756-7169

Funding

National Research Foundation of Korea (NRF-2013R1A2A2A01068868)

  • You Mie Lee

National Research Foundation of Korea (NRF-2017R1A2B3002227)

  • You Mie Lee

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Gou Young Koh, Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST), Korea (South), Republic of

Ethics

Animal experimentation: The animal handling and experimental procedures were strictly conducted as per the Guidelines for Care and Use of Laboratory Animals issued by the Institutional Ethical Animal Care Committee of Kyungpook National University

Version history

  1. Received: February 12, 2019
  2. Accepted: August 15, 2019
  3. Accepted Manuscript published: August 20, 2019 (version 1)
  4. Version of Record published: September 4, 2019 (version 2)

Copyright

© 2019, Park et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,920
    views
  • 613
    downloads
  • 42
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Myo-Hyeon Park
  2. Ae Kyung Kim
  3. Sarala Manandhar
  4. Su-Young Oh
  5. Gun-Hyuk Jang
  6. Li Kang
  7. Dong-Won Lee
  8. Do Young Hyeon
  9. Sun-Hee Lee
  10. Hye Eun Lee
  11. Tae-Lin Huh
  12. Sang Heon Suh
  13. Daehee Hwang
  14. Kyunghee Byun
  15. Hae-Chul Park
  16. You Mie Lee
(2019)
CCN1 interlinks integrin and Hippo pathway to autoregulate tip cell activity
eLife 8:e46012.
https://doi.org/10.7554/eLife.46012

Share this article

https://doi.org/10.7554/eLife.46012

Further reading

    1. Cancer Biology
    2. Cell Biology
    Alex Weiss, Cassandra D'Amata ... Madeline N Hayes
    Research Article

    High-throughput vertebrate animal model systems for the study of patient-specific biology and new therapeutic approaches for aggressive brain tumors are currently lacking, and new approaches are urgently needed. Therefore, to build a patient-relevant in vivo model of human glioblastoma, we expressed common oncogenic variants including activated human EGFRvIII and PI3KCAH1047R under the control of the radial glial-specific promoter her4.1 in syngeneic tp53 loss-of-function mutant zebrafish. Robust tumor formation was observed prior to 45 days of life, and tumors had a gene expression signature similar to human glioblastoma of the mesenchymal subtype, with a strong inflammatory component. Within early stage tumor lesions, and in an in vivo and endogenous tumor microenvironment, we visualized infiltration of phagocytic cells, as well as internalization of tumor cells by mpeg1.1:EGFP+ microglia/macrophages, suggesting negative regulatory pressure by pro-inflammatory cell types on tumor growth at early stages of glioblastoma initiation. Furthermore, CRISPR/Cas9-mediated gene targeting of master inflammatory transcription factors irf7 or irf8 led to increased tumor formation in the primary context, while suppression of phagocyte activity led to enhanced tumor cell engraftment following transplantation into otherwise immune-competent zebrafish hosts. Altogether, we developed a genetically relevant model of aggressive human glioblastoma and harnessed the unique advantages of zebrafish including live imaging, high-throughput genetic and chemical manipulations to highlight important tumor-suppressive roles for the innate immune system on glioblastoma initiation, with important future opportunities for therapeutic discovery and optimizations.

    1. Cancer Biology
    2. Cell Biology
    Ian Lorimer
    Insight

    Establishing a zebrafish model of a deadly type of brain tumor highlights the role of the immune system in the early stages of the disease.